Latest news
BeOne Medicines Shares Trading At Discount To Fair Value, RBC Says - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 18:02:36 GMTRBC Thinks BeOne’s Brukinsa Worries Look Overdone - FinimizeFinimize · Thu, 06 Aug 2026 17:48:53 GMTRBC Adjusts Price Target on BeOne Medicines to $450 From $451, Maintains Outperform Rating - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 11:21:04 GMT